Date Filed | Type | Description |
08/01/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/01/2023 |
8-K
| Quarterly results |
06/29/2023 |
144
| Form 144 - Report of proposed sale of securities: |
06/07/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
05/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
05/02/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/01/2023 |
8-K
| Quarterly results |
04/20/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
04/20/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
04/20/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/01/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/01/2023 |
8-K
| Quarterly results |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/09/2023 |
SC 13G/A
| FMR LLC reports a 15.7% stake in SURGERY PARTNERS INC |
02/09/2023 |
SC 13G
| VANGUARD GROUP INC reports a 5% stake in Surgery Partners Inc. |
02/06/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
01/09/2023 |
8-K
| Quarterly results |
12/27/2022 |
SC 13D/A
| BCPE Seminole Holdings LP reports a 29.5% stake in Surgery Partners, Inc. |
12/22/2022 |
8-K
| Quarterly results |
12/05/2022 |
SC 13G
| Durable Capital Partners LP reports a 5% stake in Surgery Partners, Inc. |
11/23/2022 |
SC 13D/A
| BCPE Seminole Holdings LP reports a 40% stake in Surgery Partners, Inc. |
11/22/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
11/22/2022 |
8-K
| Quarterly results |
11/21/2022 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
11/08/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
11/08/2022 |
8-K
| Quarterly results |
08/02/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
08/02/2022 |
8-K
| Quarterly results |
05/20/2022 |
8-K
| Quarterly results |
05/03/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
05/03/2022 |
8-K
| Quarterly results |
04/07/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
04/07/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/01/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
|